Prestige BioPharma Limited
Prestige BioPharma Limited (KRX: 950210) is trading at ₩5,960.00, about ₹430 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, up 0.51% today. Prestige BioPharma is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩5,850.00
Today's high
₩6,020.00
52 week low
₩4,945.00
52 week high
₩14,120.00
950210 opened at ₩5,940.00, closed previously at ₩5,930.00, and has traded between ₩4,945.00 and ₩14,120.00 over the past 52 weeks.
About
Established in 2015 and based in Singapore, Prestige BioPharma Limited operates as a biopharmaceutical enterprise. The company's activities encompass the research, development, and commercialization of biosimilars and novel antibody therapeutics, primarily targeting the Asia Pacific market. A significant focus for Prestige BioPharma is the creation of antibody-based treatments for critical conditions such as solid tumors, pancreatic cancer, breast cancer, gastric cancer, and arthritis. Furthermore, the firm is also advancing the development of vaccines for the COVID-19 virus.
Key statistics
Avg. volume
63.48K
Market cap
₩358.17B
P/E Ratio
-3.87
Price-to-sales ratio
13.74
Enterprise value
₩477.77B
Free cash flow yield
-16.09%
Debt-to-equity ratio
0.24
Return on equity
-21.07%
ROIC
-13.80%
Beta
0.38
Dividend yield
0.00%
Last dividend
₩0.00
Financial overview
Revenue
₩26.06B
Earnings per share
-₩1,522.10
Free cash flow
-₩62.48B
Net profit margin
-355.52%
Gross margin
-118.21%
EBITDA
-₩60.84B
Revenue growth
82.14%
Similar securities
This is not an investment recommendation
Prestige BioPharma for Indian investors
Prestige BioPharma is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Prestige BioPharma for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NonePrestige BioPharma does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
FAQs
Can I buy Prestige BioPharma on Paasa?
Prestige BioPharma (950210) has been listed on the Korea Exchange since 2021, in the Biotechnology industry. Prestige BioPharma is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Prestige BioPharma share cost in rupees?
One Prestige BioPharma share is ₩5,960.00 — about ₹430 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Prestige BioPharma price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Prestige BioPharma shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Prestige BioPharma price.
Does Prestige BioPharma pay a dividend?
No. Prestige BioPharma does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one: dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Is Prestige BioPharma a South Korea company, and does that change how it is taxed?
Prestige BioPharma trades on the Korea Exchange in KRW, but the company is domiciled in Singapore. Prestige BioPharma trades as an ordinary share listed directly in South Korea, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Prestige BioPharma shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Prestige BioPharma?
Yes. Prestige BioPharma is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.